Kairos Pharma Ltd
Officers & Directors
John Yu, M.D., serves as Chief Executive Officer and Chairman of the Board. His employment agreement, effective upon the company's IPO, provides a base salary of $175,000 annually, 14,000 restricted stock units (RSUs) vesting over three years, and eligibility for an annual cash or stock bonus. Doug Samuelson is the Chief Financial Officer with a base salary of $50,000 per year, annual grants of 50,000 RSUs vesting after 12 months, additional RSUs tied to outstanding invoices, and a provision for 250,000 RSUs upon a Change of Control. He is also eligible for an annual bonus and standard benefits, including 30 days of paid vacation and six months of severance without cause. Neil Bhowmick, M.D., is the Chief Scientific Officer with a base salary of $100,000 annually, 14,000 RSUs vesting over three years, eligibility for an annual bonus, and standard benefits including 30 days of paid vacation and six months of severance without Good Cause termination. Ramachandran Murali, M.D., serves as Vice President of Research and Development with a base salary of $80,000 per year, an initial grant of 14,000 RSUs vesting over three years, eligibility for an annual bonus, and standard benefits including 30 days of paid vacation and six months of severance without Good Cause termination.
Kairos Pharma Ltd currently has 4 employees.
|
